Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001390531 | SCV001592273 | pathogenic | not provided | 2024-01-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln171*) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is present in population databases (rs747865323, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with EYS-related conditions. ClinVar contains an entry for this variant (Variation ID: 1076583). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005038210 | SCV005672769 | likely pathogenic | Retinitis pigmentosa 25 | 2024-06-15 | criteria provided, single submitter | clinical testing |